Publications
Origin-1: a generative AI platform for de novo antibody design against novel epitopes
IgDesign: In vitro validated antibody design against multiple therapeutic antigens using inverse folding
Development of ABS-101: A potential best-in-class anti-TL1A antibody for the treatment of IBD
IgDesign: Antibody inverse folding with in vitro validation
Human anti-MAGEA Antibodies Derived from Tertiary Lymphoid Structures of Cancer Patients
Evaluating Zero-Shot Scoring for In Vitro Antibody Binding Prediction with Experimental Validation
Scaling Data and AI for Multioptimized Biologics
Better Lead Optimization with AI
De Novo Antibodies Designed with AI
Codon Optimization with Deep Learning Models
